Cisplatin Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/50 mL, 100 mg/100 mL
Reference Brands: Platinol® (EU & US)
Category: Oncology Cancer Care
Cisplatin is an intravenous chemotherapy used for testicular, ovarian, bladder, lung, and head and neck cancers. Available in 50 mg/50 mL and 100 mg/100 mL injections in the US and EU. Cisplatin is available in Injection and strengths such as 50 mg/50 mL, 100 mg/100 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cisplatin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Cisplatin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Cisplatin, marketed as Platinol®, is a platinum-based chemotherapy drug widely used in the treatment of various cancers, including testicular, ovarian, bladder, lung, and head and neck cancers. Available in 50 mg/50 mL and 100 mg/100 mL intravenous formulations, Cisplatin works by disrupting DNA replication in cancer cells. Manufactured under GMP guidelines, it provides significant opportunities for B2B oncology pharmaceutical companies targeting hospitals, oncology clinics, and healthcare providers in both US and EU markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Motixafortide Acetate
Strength:
1 mg/mL
Form: Injection
Reference Brands: Aphexda (USA)
View DetailsMomelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View DetailsNirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers